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This paper outlines a preliminary study that was conducted to review, test, and improve 
on current space suit biocontamination control. Biocontamination from crew members can 
cause space suit damage and objectionable odors and lead to crew member health hazards. 
An understanding of the level of biocontamination is necessary to mitigate its effects. A 
series of tests were conducted with the intent of evaluating current suit materials, ground 
and on-orbit disinfectants, and potential commercial off-the-shelf antimicrobial materials. 
Included in this paper is a discussion of the test methodology, results, and analysis method. 
Nomenclature 
ACES = Advanced Crew Escape Suit 
BladderG = ACES GORE-TEX
™
 bladder 
BladderU = EMU polyurethane-coated nylon bladder 
CFU = colony-forming unit 
COTS = commercial off-the-shelf 
CSSE = Constellation Space Suit Element 
CxP = Constellation Program 
EMU = EVA Mobility Unit 
EVA = extravehicular activity 
HPC = heterotrophic plate count 
LCG = liquid cooling garment 
LCVG = liquid cooling ventilation garment 
LCVG-L = LCVG-inner layer 
LCVG-O = LCVG-outer layer 
PA = polyamide 
PBS = phosphate buffer saline 
PET = polyester (polyethylene terephthalate) 
PGS = pressure garment suit 
SDA = Sabouraud dextrose agar 
TCU = thermal comfort undergarment 
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I. Introduction 
This paper outlines a preliminary study to understand the current state of space suit biocontamination control. The 
study includes an evaluation of current and advanced space suit materials, ground and on-orbit cleaning methods, 
and microbial test and analysis methods. Biocontamination from crew members during extravehicular activities 
(EVAs) can lead to suit damage, odors, and crew member health hazards. It is advantageous to reduce the level of 
biocontamination on a space suit to lessen this risk.
1 
The first stage of this study was to identify potential antimicrobial textiles and cleaning agents. The antimicrobial 
cleaning agent and textile market survey focused on current commercial off-the-shelf (COTS) products that could 
potentially be used as future space suit materials, replacing any currently used soft-good layers that may become 
contaminated during an EVA, including the pressure bladder, liquid cooling garment (LCG), and ancillary thermal 
comfort undergarment (TCU). 
The second stage of this study was to review standardized test procedures (AATCC, ASTM, etc.) to evaluate how 
current and advanced materials could be evaluated. A customized test procedure, developed after consideration, is 
discussed within this paper. 
Finally, four tests were conducted to evaluate current and COTS materials and cleaning agents: (1) a test of the 
stacked layers arrangement of current suit materials to understand how biocontamination propagates through the 
various suit layers; (2) a test of each current suit material layer to evaluate the efficacy of each soft-good layer to 
repress microbial growth; (3) an efficacy test for the suppression of microbial growth by cleaning agents on each of 
the current suit bladder materials; and (4) a test evaluation of the efficacy of various COTS antimicrobial textiles to 
suppress microbial growth. 
All antimicrobial COTS materials tested appeared to control bacterial colony-forming unit (CFU) growth better 
than the TCU and the Advanced Crew Escape Suit (ACES) LCG/Extravehicular Activity Mobility Unit (EMU) 
liquid cooling ventilation garment (LCVG). However, a comparison of fungal CFU growth in COTS to current suit 
materials appeared to vary with material. The EMU polyurethane-coated nylon bladder also seems to be more 
responsive to cleaning than the ACES GORE-TEX
™
 (W. L. Gore and Associates, Inc., Newark, DE). Other trends 
and a series of test improvements for future microbial testing are discussed below. 
II. Study Methodology 
A. Evaluation of the Problem 
Prolonged microbial growth in a space suit presents hygienic and functional risks, including foul odors rendering 
the suit unusable, health hazards, and operational risks due to textile degradation. These risks must be evaluated as 
the U.S. human space program moves toward planned long-term missions beyond low Earth orbit (LEO). Thus, 
there is a need for a comprehensive, systematic study on suit biocontamination. Previous studies have evaluated the 
frequency of cleaning and its influence on the life of suit components,
1
 but no extensive research has been 
undertaken on the use of different textile materials and technologies to control microbial growth. 
As NASA continues to shift its focus from LEO to exploration beyond LEO, the effects of biocontamination 
become a greater concern for the health of the suit and the crew members. This concern was also made evident in 
the recent Constellation Program’s requirements. The Constellation Program (CxP) operations concept included 
confined and limited habitable spaces in which the space suit is used as many as 90 times over 6 months for lunar 
missions, and stored as many as 210 days on Orion-based missions to the International Space Station or other near-
Earth-orbit destinations.  
The specification used in this study for microbial contamination level limitation is provided in Reference 2. This 
document was used to write the requirements for acceptable Constellation space suit element (CSSE) biocontamination 
levels, as listed in Reference 3. The two applicable requirements from the Element Requirement Document (ERD, 
Reference 3) are: 
 
1. [CSSE1105] Microbial Contamination 
The pressure garment suit (PGS) shall limit the level of microbial contamination on the interior surface of the 
bladder to 4106 CFU/100 cm2 or fewer following the post-doff cleanup procedure and subsequent storage for up to 
210 days. 
2. [CSSE1142] Fungal Contamination 
The PGS shall limit the level of fungal contamination on the interior surface of the bladder to 100 CFU/100 cm
2
 
or fewer following the post-doff cleanup procedure and subsequent storage for up to 210 days. 
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B. Antimicrobial Materials Selection 
As a wealth of textile fabrics and antimicrobial technologies exist, the challenge in material selection is to identify 
the most likely textile candidates for in-suit materials. This section provides background information on the different 
types of anti-microbial materials and describes the selection process that was used for this test. 
Textiles made of natural fibers can discolor or rot from microbial attack, especially if they are kept in hot and 
humid conditions. Synthetic fibers are inherently resistant to microbial attack and to decomposition, but are good 
substrates for microbial growth, especially those used for lingerie and undergarments. 
The sportswear, underwear, and shoe-lining industries are now selling a variety of antimicrobial textiles. These new 
textiles have incorporated active antimicrobial agents such as silver, copper, quaternary ammonium salts, 
polyhexamethylene biguanide, organo-silanes, triclosan, chitosan, dyes, and regenerable N-halamine compounds and 
peroxyacids. Although antimicrobial agents are divided into biocides and biostats, biocides account for most of the 
market growth. Antimicrobial agents are attached to the fabric surface or incorporated within the fiber. As their 
name suggests, they can stop microbial growth by inhibition or destruction of the microorganisms through one or 
more of the following mechanisms: cell wall damage, inhibition of cell wall synthesis, alteration of cell wall 
permeability, inhibition of the synthesis of proteins and nucleic acids, and/or inhibition of enzyme action. The 
biocidal agents used in the textile industry can be divided in two general categories: those used for cellulosic or 
synthetic fibers.  Chitosan, N-halamine, and peroxyacids are usually bonded to cellulosic cotton, whereas metals are 
added to synthetic fibers. These agents can also be divided into leaching and affixed agents. 
Leaching agents are disadvantageous because they create a zone of inhibition with a concentration gradient from 
the source to the edge. This means that a sublethal effect is likely to be found with these types of antimicrobial 
agents, and new generations of resistant microbes may be selected in the process. 
Affixed agents bond to fibers or fabrics. Most antimicrobial textiles contain these agents, which work by physically 
and ionically attacking microbes. Metal ions and oxides belong to this category. 
Currently, silver and copper are the most commonly used antibacterial additives in textiles. Both silver and copper 
host a number of advantages: they have a high degree of biocompatibility, excellent resistance to sterilization, and 
broad spectrum antibacterial properties. 
The selection of antimicrobial fabric samples in this study was based on the following requirements: 
 Use with synthetic fibers for space suit fabrics 
 Durability to washing, dry cleaning, hot pressing 
 Broad biocidal effect (gram-positive and gram-negative bacteria, and fungi) and non-leaching 
 Compliance with statutory requirements in terms of toxicity and environmental impact 
 Resistance to sterilization 
 Market availability (penetration into the performance apparel market as in the number of products with silver-
nanoparticle-impregnated fibers) 
 
Table 1. Commercial Off-the-shelf Antimicrobial Fabric Candidates 
Product Identification Materials Material Content by % Weight 
Cupron™* NASA-2 PET/copper oxide 98/2 
Cupron™ NASA-4 PET/copper oxide 98/2 
Cupron™ NASA-5 PET/copper oxide 98/2 
UNITED KNITTING
†
 80031 PET/PA/Ag ion 92/7/1 
UNITED KNITTING 65961 PET/PA/Ag ion/spandex 20/58/8/14 
KAOS** PA/Ag ion/spandex 79/11/10 
SILVERCLEAR
® †† 
PA/Ag chloride Unknown 
HYGY™ ***  
H3 TTM175-80 MA 
PET/silicone derivative Unknown 
*Cupron, Inc., Richmond, VA. 
†
UNITED KNITTING, Cleveland, TN. 
**KAOS Worldwide, Stafford, TX. 
††
TransTex Technologies International, Plandome, NY. 
***KTTEX Corporation, King Tech Group, San Diego, CA. 
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Since metal additives are prevalently used for performance apparel, both silver- and copper-impregnated fabrics 
were chosen for this study. Novel silicone-treated fabric was also included for comparison. Table 1 shows the compo-
sition of the eight fabrics selected for this study: three polyester (PET) fabrics of different construction and weight 
doped with copper oxide, three blended fabrics (PET and polyamide [PA]) containing different amounts of silver ions 
in the nylon fibers, one fabric coated with silver chloride, and one fabric treated with silicone. 
Other factors that were not controlled in this study (e.g.,antimicrobial agents mass and availability and fabric 
construction) could not be examined here. 
C. Test Process 
Several standard test processes were evaluated, but did not meet study requirements in terms of cost, material 
quantity, or time. A custom test process was therefore developed for each of the four tests. This test process is de-
scribed in the following subsection on common test procedures. References are made in the common test procedure 
to following subsections for each of the four tests. 
1. Common Test Procedures 
Textiles were cut into 2x2 inch squares and incubated in sterile Petri dishes (Fisher Scientific, Pittsburgh, PA). 
To ensure that there was limited contact between the textile and the surface of the Petri dish so as to maintain air 
flow, sterile weighted objects were placed on the bottom of the Petri dish. Textiles in their respective arrangements 
were then placed on top of weighted objects. Once in configuration, 1mL of a bacterial and fungal consortium 
consisting of Staphylococcus epidermidis, Escherichia coli, Penicillium species, and Candida albicans at 
concentrations given in the test subsections below was added to each arrangement, but not to the controls. Half a mL 
of Phosphate Buffer Saline (PBS) was added to sterile the Petri dishes to prevent the textiles from drying. 
For this study, a saturation assumption has been made for each microbe concentration in the inoculant.  It has 
been assumed that when each material coupon is inoculated with 1 ml of inoculant, the initial concentration is above 
the carrying capacity of the coupon due to the material and the area of the coupon.  This assumption implies that 
each coupon is carrying its intrinsic maximum viable concentration at the time of inoculation.  Any excess beyond 
this intrinsic maximum viable concentration either is shed from the coupon or fails to survive. 
The importance of the saturation assumption is that a meaningful analysis can be done in terms of colony 
forming units per milliliter (CFUs/ml) rather than in terms of the proportion of reduction of CFUs/ml from the initial 
concentration. 
The Petri dishes were incubated at 25
o
C and 98% relative humidity, which is representative of worst-case on-
orbit stowage conditions. After an initial incubation period of 16 hours, samples were processed differently, as 
indicated in the test subsections below. 
Following incubation, samples were removed for microbial analyses at the times given in test subsections below. 
Each textile was placed in a sterile conical tube with 10mL of PBS. After vortexing, serial dilutions were performed 
for each sample. Aliquots of the serial dilution suspensions were plated on Blood Agar and Sabouraud Dextrose 
Agar (SDA) for the recovery of bacteria and fungi, respectively. Blood Agar plates were incubated at 35⁰C for 2 
days whereas SDA plates were incubated at 30⁰C for 5 days. For each sample removal day, there were three treated 
samples and one control sample per fabric or layer type. Heterotrophic plate counts were completed after incubation 
and recorded as Colony Forming Units (CFU)/mL. 
2. Evaluation of Extravehicular Mobility Unit and Advanced Crew Escape Suit Materials in the Stacked and the 
Individual Arrangements (Tests 1 and 2) 
The ACES and EMU suits are each composed of three garments, as listed below:  
 EMU Stack  
o TCU – Capilene® 1 (Patagonia, Inc., Ventura, CA) 
o LCVG (both layers) – nylon tricot and nylon with spandex 
o Bladder – urethane-coated nylon 
 ACES Stack 
o TCU – Capilene® 1 
o LCG – Capilene® 4 
o Bladder – GORE-TEX™ 
Once in configuration, 1 mL of a bacterial and fungal consortium consisting of Staphylococcus epidermidis, 
Escherichia coli, Penicillium species, and Candida albicans at 2x10
3 
, 1.4104, 4102, and 2.6105 CFU/mL, 
respectively, was added to each configuration, but not to the controls.  
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After an initial incubation period of 16 hours, samples were carefully separated into three individual layers to 
simulate garments being doffed and stored after an EVA. For the stacked arrangement, each single layer textile was 
transferred into sterile Petri dishes and returned to the incubator. 
Samples were removed from incubation on days 1, 3, 7, 10, and 14 for microbial analyses 
3. Evaluation of the Disinfectants on Bladder Materials for the Extravehicular Mobility Unit and Advanced Crew 
Escape Suit (Test 3) 
The primary objective of this test was to identify the efficacy of disinfectants in removing microbes on bladder 
material for each suit (i.e., the EMU and the ACES) that was evaluated. 
Except for controls, 1 mL of a bacterial and fungal consortium consisting of Staphylococcus epidermidis, E. coli, 
Penicillium species, and Candida albicans at 5103 , 1104, 1.7106, and 1103 CFU/mL, respectively, was added to 
each arrangement 
After initial incubation, each textile was wiped with a 2.52.5-cm (11-in.) foam wipe impregnated with either 
10% Stericide [Stepan BTC 2125M], Opti-cide-3
®
 [Micro-Scientific Industries], 50% Maquat
®
 [Mason Chemical 
Company, Arlington Heights, IL], or 70% isopropanol. Samples were returned to the incubator after cleaning. 
Samples were removed from incubation on days 1, 3, 7, 10, and 14 for microbial analyses. 
4. Evaluation of Antimicrobial Materials (Test 4) 
We evaluated eight textiles that were treated with either copper, silver, silver salt, or organic components at 
various concentrations to ascertain their resistance to microbial colonization. 
Except for controls, 1 mL of a bacterial and fungal consortium consisting of Staphylococcus epidermidis, E. coli, 
Penicillium species, and Candida albicans at 1103, 4103, 2.8105, and 6x103 CFU/mL, respectively, was added to 
each arrangement.  
Samples were removed from incubation at hours 3 and 7, and at days 1, 7, and 14 for microbial analysis. 
D. Randomization 
It was necessary to randomize the assignment of coupons to Petri dishes to minimize or to compensate for the 
effect of any systematic heterogeneous condition or contamination of fabric stock during the course of manu-
facturing, shipping, and handling. Since the Petri dish labels correspond to treatments to be applied to the coupons, 
this random assignment is equivalent to a random assignment of coupons to treatments. 
The fabric stock was already cut into coupons, and the coupons were already possibly shuffled in the process. 
This means that the systematic location of the coupons across the stock was lost. However, this still did not assure 
that the coupons were in a random order with respect to their original location in the stock. This situation was 
remedied by a random association of coupons with Petri dishes. 
For the stacked suit materials, the experiment had progressed too far for randomization to be implemented. 
For the individual-layer suit materials experiment, the stack of coupons was taken in its existing order. Individual 
coupons were assigned to labeled Petri dishes in random order, separately for each coupon type (TCU, LCG, LCVG-L 
[LCVG-inner layer], LCVGO [LCVG-outer layer], BladderG [ACES GORE-TEX
™
 bladder], and BladderU [EMU 
polyurethane-coated nylon bladder]). 
The stack of coupons was taken in its existing order for the suit bladder materials experiment. Individual coupons 
were assigned in random order to the labeled Petri dishes. Additionally, to minimize any systematic effects due to 
technique in cleansing the bladder coupons with the disinfectant wipes, the order in which the coupons were wiped 
was also randomized. 
The stack of coupons was taken in its existing order for the antimicrobial materials experiment. Individual coupons 
were assigned in random order to the labeled Petri dishes, separately for each coupon type (Cupron
™
 NASA-2, 
Cupron
™
 NASA-4, Cupron
™
 NASA-5, UNITED KNITTING 65961, UNITED KNITTING 80031, KAOS, HYGY
™
, 
and SILVERCLEAR
®
). 
III. Test Results and Discussion 
This section presents the results and a discussion of those results for the following four suit material, disinfectant, 
and antimicrobial material test: 
 Evaluation of EMU and ACES Materials in Stacked Arrangement 
 Evaluation of EMU and ACES Materials in Individual Arrangement 
 Evaluation of Disinfectants on Bladder Materials for EMU and ACES 
 Evaluation of Antimicrobial Materials 
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The figures in this section are separated into bacteria (E. coli) and fungi (Penicilium and Candida) categories in 
an attempt to make comparisons easier with current CxP CSSE recommendations. Note that Staphylococcus epidermidis 
was included in the test samples but does not appear in any of the resulting data. This is because all Staphylococcus 
epidermidis CFUs decreased to a statistical zero prior to any sample testing. This may mean that the samples tested 
are not conducive to Staphylococcus epidermidis growth or this biocontaminant was easily overtaken by competing 
bacteria or fungi. Further testing is required to understand better the absence of Staphylococcus epidermidis in all 
test results. 
Since this study measured actual contamination in CFU/mL instead of CFU/cm
2
, which is a reference point, 
defined in CxP CSSE requirements, the following correlations were made: 4106 CFU/100 cm2 for bacteria is 
equivalent to 1106 CFU/mL, and 100 CFU/100 cm2 for fungi is equivalent to 2.510 CFU/mL. As a result, each 
figure in this section containing bacterial data has a dashed line at 1106 CFU/mL, and each fungi-related figure has 
a dashed line at 2.510 CFU/mL. CFU levels below these dashed lines were assumed to be desirable and generally 
safe to humans. Future discussion and testing may be needed to validate these assumptions. Furthermore, a method 
for accurately verifying actual bacterial and fungal content in space suit materials may also be essential. 
Note that time “zero” in each of the following subsections started when the sample was inoculated, indicating the 
inoculant concentration. The following subsections present the statistically analyzed data, with error bars denoting a 
95% confidence level. 
A. Test 1 – Evaluation of Extravehicular Mobility Unit and Advanced Crew Escape Suit Materials in Stacked 
Arrangement 
Bacterial colonization growth in both EMU and ACES stacked arrangement samples (with the exception of the 
EMU bladder) appeared to increase during the first 3 days, as shown in Fig. 1 and Fig. 3. After the third day, the 
bacterial levels appeared to reach a somewhat constant state. 
The total number of fungal CFUs in both EMU and ACES stacked arrangement samples appeared to slightly 
decrease with time, as shown in Fig. 2 and Fig. 4. The fungal levels of the TCU, LCG, and LCVG samples appeared 
quickly to reach a somewhat constant state, whereas the ACES bladder sample showed slight growth between days 1 
and 3, followed by a gradual decrease for the remainder of the 14-day test period. All ACES and EMU layers 
(except the EMU bladder) appeared to exceed CxP CSSE recommended limits for maximum fungal CFU levels. 
Bacteria and fungi EMU bladder data for the stacked arrangement also exhibited a significant initial decrease. 
However, when the statistical data were processed for the EMU bladder case, the number of CFUs was so small the 
statistical analysis considered these data points to be zero; they were therefore not included in this data analysis. 
1. Extravehicular Mobility Unit Stacked Arrangement 
Figure 1 shows that bacterial CFU levels in the EMU stacked arrangement TCU and LCVG generally exceed the 
current recommended CxP CSSE levels for most of the test after the first day. The EMU stacked arrangement 
polyurethane-coated nylon bladder had insufficient data to be statistically relevant for inclusion in this graph. 
However, the raw data indicate that CFU levels in the EMU layer appear to be below the recommended CxP CSSE 
maximum CFU levels for the entire 14-day duration of the test. 
 
Figure 2. Fungi HPC (CFU/mL) of EMU material in 
stacked arrangement. 
 
 
Figure 1. Bacteria heterotrophic plate count (HPC) 
(CFU/mL) of EMU material in stacked arrangement. 
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Figure 2 shows that the fungal CFU levels in the EMU stacked arrangement TCU and LCVG generally exceeded 
the current recommended CxP CSSE maximum levels for most of the 14-day test period. The EMU stacked 
arrangement polyurethane-coated nylon bladder layer data do not appear on this graph because statistically there was 
no CFU growth during any of the samples. 
2. Advanced Crew Escape Suit Stacked Arrangement 
Figure 3 shows that bacterial CFU levels in all layers of the ACES stacked arrangement generally exceed the 
current recommended CxP CSSE maximum levels for most of the test after the first day. 
Figure 4 shows that fungal CFU levels in all layers of the ACES stacked arrangement generally exceeded the 
current recommended CxP CSSE maximum levels for most of the 14-day test period. The ACES TCU and LCG 
appeared to follow a similar trend, while the ACES bladder appeared to show a continued decrease in bacterial 
CFUs through day 14. Additional testing may need to be performed to determine whether this decrease continues to 
levels recommended by CxP CSSE requirements after 14 days. 
B. Test 2 – Current Suit Material Individual Arrangement 
Bacterial colonization growth in the TCU and LCVG-L layers of the EMU individual arrangement samples and 
all layers of the ACES individual arrangement samples appeared to increase during the first 3 days, as shown in Fig. 
5 and Fig. 7. After the third day, these bacterial levels appeared to reach a constant state. This bacterial CFU 
behavior in the individual TCU and LCVG-L layer arrangements appears to be similar to the behavior found in the 
stacked TCU, LCVG/LCG, and ACES bladder layer arrangements. 
Bacterial colonization growth in the LCVG-O and bladder layers of the EMU experienced an initial decrease 
during the first day before increasing for the remainder of the 14-day study. Additional testing is needed to determine 
the reason for the initial decrease in these layers and how many additional days are needed before the bacterial CFUs 
reach a constant level of CFU/mL. 
Fungal colonization growth in all layers of the EMU and ACES individual arrangements showed a noticeable 
decrease in the first day sample, as shown in Fig. 6 and Fig. 8. The fungal levels in all samples continued to increase 
after the first day, and did not appear to level off during the 14-day test. Additional testing is needed to determine 
how many days these fungal CFU increases will continue before they level off or reach a steady state. 
Note that since Capilene
®
 is the same material used for both the EMU and the ACES TCU, it was tested once, 
and the same TCU data were then duplicated in individual arrangement EMU and ACES figures in this subsection 
for comparison. 
1. Extravehicular Mobility Unit Individual Layer Arrangement 
Figure 5 shows that, after the first day, bacterial CFU levels in the EMU TCU and LCVG layer generally exceeded 
the current recommended CxP CSSE maximum CFU levels for most of the test. The EMU LCVG-O and bladder 
layers showed an initial decrease, followed by continued growth. These layers generally did not appear to exceed the 
CxP CSSE recommendation for bacterial CFU levels within the 14-day test period. 
 
Figure 3. Bacteria HPC (CFU/mL) of ACES material 
in stacked arrangement. 
 
 
Figure 4. Fungi HPC (CFU/mL) of ACES material in 
stacked arrangement. 
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Figure 6 shows that the fungal CFU levels in all layers of the EMU individual arrangement generally exceeded 
the current CxP CSSE recommended maximum levels for the duration of the 14-day test period, with the exception 
of the EMU bladder on day 3. The EMU LCVG-O and bladder fungal CFU levels were noticeably less than those of 
the TCU and LCVG-L, which is similar to what was observed in Fig. 5 for the bacterial testing. Fungal CFU levels 
in all EMU layers appeared to continue to increase after the first day for the duration of the 14-day test. Longer 
testing is needed to determine if these fungal CFU increases level off or reach a steady state. 
2. Advanced Crew Escape Suit Individual Layer Arrangement 
Figure 7 shows that bacterial CFU levels in all ACES individual layers generally exceeded the current CxP 
CSSE recommended maximum CFU levels for most of the test. The behavior of bacterial CFUs in the ACES indi-
vidual layer appeared to be similar to that of the ACES stacked arrangement, as shown in Fig. 3. 
Figure 8 shows that the fungal CFU levels in all layers of the ACES individual arrangement undergo an initial 
decrease during the first day and then gradually increased or leveled off for the remainder of the 14-day study. This 
was in slight contrast to the fungi behavior found in the ACES stacked arrangement (shown in Fig. 4), which exhibited 
the same initial decrease, but then continued to decrease during the remainder of the 14-day study. This may imply 
that fungi growth in the ACES layers behaves differently in the individual and the stacked arrangements. The fungi 
levels for both the stacked and the individual arrangements generally exceeded the current CxP CSSE recommended 
maximum levels for most of the 14-day test period. 
C. Test 3 – Evaluation of Disinfectants on Extravehicular Mobility Unit and Advanced Crew Escape Suit 
Bladders 
Evidence of bacterial and fungal CFU growth on all EMU bladder samples treated with selected disinfectant was 
substantially reduced within 7 days, as shown in Fig. 9 and Fig. 10. Evidence of bacterial and fungal CFU growth on 
ACES bladder material treated with disinfectant is shown in Fig. 11 and Fig. 12. CFU growth on samples treated 
 
Figure 5. Bacteria HPC (CFU/mL) of EMU material 
in individual arrangement. 
 
 
Figure 6. Fungi HPC (CFU/mL) of EMU material in 
individual arrangement. 
 
 
Figure 7. Bacteria HPC (CFU/mL) of ACES material 
in individual configuration. 
 
 
Figure 8. Fungi HPC (CFU/mL) of ACES material 
in individual configuration. 
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with isopropanol or Stericide appears to be similar to individual ACES bladder samples that were not treated with 
any disinfectant, as shown in Fig. 8 and Fig. 9. Additional testing is needed to determine whether these disinfectants 
are effective at lowering CFU levels. 
1. Disinfectants on Extravehicular Mobility Unit Materials 
Figure 9 shows that the bacterial CFU growth for all treated EMU bladder samples was below the current CxP 
CSSE recommended maximum CFU levels for the duration of the 14-day test. In this figure, EMU bladder samples 
treated with isopropanol, Opti-Cide-3
®
, and Maquat
®
 did not have enough data to be statistically relevant due to the 
large number of samples that contained zero bacterial CFUs 1 day after inoculation. Only the samples treated with 
Stericide contained measurable amounts of bacteria on days 1 and 3 before going to statistically zero by day 7. 
Additional testing, including a larger sample set, is needed to facilitate statistically relevant data for these disinfec-
tants. Figure 9 also includes the bacterial CFU growth in the untreated EMU bladder individual layer arrangement, 
previously shown in Fig. 5. The untreated EMU bladder individual layer is included in this figure to show that each 
of the disinfectants appears to inhibit bacterial CFU growth better than the untreated bladder alone. 
Figure 10 shows that fungal CFU growth for EMU bladder treated with disinfectant remained below the current 
CxP CSSE recommended maximum levels for the14-day duration of this test, with the exception of the first day 
when materials treated with Stericide exceeded this recommendation. In this figure, the EMU bladder samples 
treated with isopropanol, Opti-Cide-3
®
, and Maquat
®
 did not have enough data to be statistically relevant due to the 
large number of samples that contained zero fungal CFUs 1 day after inoculation. Only samples treated with 
Stericide contained sufficient amounts of bacteria on day 1 before going to statistically zero by day 7. Additional 
testing, including a larger sample set, is needed to facilitate statistically relevant data for these disinfectants. Figure 
10 also includes the fungal CFU growth in the untreated EMU bladder individual layer arrangement, previously 
shown in Fig. 5 and Fig. 6. The untreated EMU bladder layer is included in Fig. 10 to show that each of the 
disinfectants appears to inhibit fungal CFU growth better than the untreated bladder alone, with the exception of the 
bladder treated with isopropanol on day 1. Additional testing is needed to determine why the bladder treated with 
isopropanol has higher fungal CFU growth than the untreated EMU bladder at day 1. 
2. Disinfectants on Advanced Crew Escape System Materials 
Figure 11 shows that bacterial CFU growth in ACES bladder samples treated with Maquat
®
 or Opti-Cide-3
®
 for 
the ACES bladder generally remained below the current CxP CSSE recommended maximum CFU levels for the 14-
day duration of this test. Bacterial CFU growth in ACES bladder samples treated with isopropanol or Stericide 
remained at higher levels until day 10, when bacteria in these samples began to slightly decrease. Additional testing 
is needed to determine whether these bacterial CFU levels continue to decrease with time or when they reach a 
steady state. Figure 11 also includes the bacterial CFU growth in the untreated ACES bladder individual layer 
arrangement, previously shown in Fig. 7. The untreated ACES bladder layer is included in this figure to demonstrate 
that each of the disinfectants appears to inhibit bacterial CFU growth better than the untreated bladder alone. 
Figure 12 shows that the fungal CFU growth on ACES bladder samples treated with isopropanol or Stericide 
exceeded the current CxP CSSE recommended maximum CFU levels for the14-day duration of this test. Fungal 
CFU growth in ACES bladder samples treated with Maquat
®
 or Opti-Cide-3
®
 were statistically zero for days 1, 3, and 
7.  After day 7, samples that had been treated with Opti-Cide-3
®
 statistically remained at zero while those treated 
 
Figure 9. Bacteria HPC (CFU/mL) of disinfected 
EMU bladder material. 
 
 
Figure 10. Fungi HPC (CFU/mL) of disinfected 
EMU bladder material. 
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with Maquat
®
 began to show an increase in CFU growth and exceeded the CxP CSSE recommended levels on day 
14. Additional testing is needed to determine whether bacteria CFU levels will continue to increase with time or 
when they reach a steady state. Figure 12 also includes the fungal CFU growth in the untreated ACES bladder 
individual layer arrangement, previously depicted in Fig. 8. The untreated ACES bladder layer is included in Fig. 12 
to show that each of the disinfectants appears to inhibit fungal CFU growth better than the untreated bladder alone, 
with the exception of the bladder treated with isopropanol on day 14. Additional testing is needed to determine why 
the bladder treated with isopropanol has higher fungal CFU growth than the untreated ACES bladder on day 14. 
 
 
D. Test 4 – Antimicrobial Commercial Off-the-shelf Materials 
Results for the tested COTS materials were separated into materials that used copper-oxide-doped fiber tech-
nology (Fig. 13 and Fig. 14) and those that used either silver-ion-coated fibers or organic treatments (Fig. 15 and Fig. 
16). This separation was made to simplify the presentation of the figures in this subsection. Materials with copper-
oxide-treated fibers appeared to control bacteria CFU growth better than those with silver-ion treatments. Both ions 
appeared to have similar behavior related to fungal growth control. Since the copper-oxide fibers were doped and 
the silver-ion fibers were coated fibers, additional testing needs to be performed to better understand the effect of 
ions and fiber treatment on CFU growth. 
Note that there are no statistical data on samples using SILVERCLEAR
®
 disinfectant because this disinfectant 
appeared to eliminate all bacteria and fungi within the first 3 hours after application. Statistical statements 
concerning the effect of SILVERCLEAR
®
 were not possible in this situation. 
All copper-doped fiber samples appeared to maintain bacterial CFU levels under the current CxP CSSE maximum 
CFU recommendation during the 14-day test period. The Cupron™ NASA-2 and Cupron™ NASA-5 samples actually 
 
Figure 11. Bacteria HPC (CFU/mL) of disinfected 
ACES material. 
 
 
Figure 12. Fungi HPC (CFU/mL) of disinfected 
ACES material. 
 
 
Figure 13. Bacteria HPC (CFU/mL) of copper-doped 
antimicrobial material. 
 
 
Figure 14. Fungi HPC (CFU/mL) of copper-doped 
antimicrobial material. 
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achieved statistically zero bacterial CFU at the end of 14 days, while the Cupron™ NASA-4 sample continued to 
increase bacterial CFU levels with each sample. Note that all Cupron™ samples used the same type of antimicrobial 
agent, but they used a different fabric weave. This weave dissimilarity may be responsible for the difference in both 
bacterial and fungal growth, but further testing is needed to substantiate this observation. 
All copper-doped fiber samples appeared to continue to increase fungal CFU levels with time and generally re-
mained above the current CxP CSSE recommended maximum CFU levels for the duration of the test, as shown in 
Fig. 14. 
All silver and organic samples appeared to maintain bacterial CFU levels under the current CxP CSSE maximum 
CFU recommendation during the 14-day test period; however, HYGY™ and KAOS appeared to be increasing in 
bacteria CFU levels toward the end of the testing period. If the rates observed between days 7 and 14 continue, these 
samples may exceed CxP recommended levels, but further testing is required to substantiate this observation. 
Bacterial and fungal CFU levels for UNITED 
KNITTING 65961 were statistically zero at the end of the 14-day test period. Fungal levels in HYGY™ and 
UNITED KNITTING 80031 generally exceeded CxP CSSE recommended levels for maximum CFUs, while 
UNITED KNITTING 65961 and KAOS showed decreases in CFU levels from day 7 to day 14, as shown in Fig. 16. 
UNITED KNITTING 65961 appeared to be below recommended CFU levels from day 3 to the end of the 14-day 
duration test. 
E. Statistical Analysis 
Negative binomial regression was used to relate the microbial counts to the applied treatments and to calculate the 
estimated effects and their confidence limits at the follow-up times.  For Tests 1, 2, and 3, these follow-up times are 
1, 3, 7, 10, and 14 days after inoculation.  For Test 4, the follow-up times are 1 and 3 hours and 1, 7, and 14 days 
after inoculation.  The statistical model includes a scale parameter k, as follows.  If y is the number of colony 
forming units, with mean value  , then the probability for y is 
 
 
   
    ,2,1,0,1
1/1
/1 /1
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
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yp
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 . 
The variance of y is 
2 k .  The parameter k is a scale parameter because the variance of y changes linearly 
with k. 
In all of the analyses, the mean   was expanded as a linear function of the effects of treatments, such as 
microbial type, material type, antimicrobial agent, and incubation time. 
The statistical analysis produces no statements about the microbial counts at time zero, since no measurements 
were taken at that time concerning the effect of the treatments.  Statements about increases or decreases in CFUs 
over time are based on differences in counts from one follow-up time to another and not on differences in counts 
from the initial microbial concentration.  As such, significant differences may imply an increasing or decreasing 
trend over the follow-up times but not with respect to the initial concentrations.  This analysis is based in part on the 
saturation assumption given above in section II, subsection C, sub-subsection 1, paragraphs 2 and 3. 
 
Figure 16. Fungi HPC (CFU/mL) of silver and 
organic-based antimicrobial materials. 
 
 
Figure 15. Bacteria HPC (CFU/mL) of silver and 
organic-based antimicrobial materials. 
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For the stacked suit materials arrangement, there were no statistically significant differences at the 5% 
significance level for estimated day-to-day increases or decreases in estimated CFU counts for three out of the four 
day-to-day differences.  Significant increases or decreases at the 5 percent significance level in estimated CFU 
counts over the entire follow-up period of 14 days are reported in Table 2.   
Table 3 summarizes comparisons of significant differences at the 5 percent significance level in estimated CFU 
counts for selected materials by Microbes and follow-up Day. 
 
Table 2. Overall Follow-up Microbial Change: 
Stacked Suit Materials 
Material Microbes p-Value Significant 
Overall 
Increase 
Significant 
Overall 
Decrease 
BladderG Bacteria 0.0010 Yes No 
BladderG Fungi <.0001 No Yes 
LCG Bacteria <.0001 Yes No 
LCG Fungi 0.0134 No Yes 
LCVG Bacteria <.0001 Yes No 
LCVG Fungi 0.3335 No No 
TCU_A Bacteria 0.0241 Yes Yes 
TCU_A Fungi <.0001 No Yes 
TCU_E Bacteria <.0001 Yes No 
TCU_E Fungi 0.0257 No Yes 
 
Table 3. Selected Sources of Microbial Change Due to Materials: 
Stacked Suit Materials 
Microbes Day LCG vs LCVG TCU_A vs TCU_E 
Bacteria 1 Yes Yes 
Bacteria 3 No Yes 
Bacteria 7 Yes No 
Bacteria 10 No No 
Bacteria 14 Yes Yes 
Fungi 1 Yes No 
Fungi 3 No No 
Fungi 7 Yes No 
Fungi 10 Yes No 
Fungi 14 Yes No 
 
For the individual suit materials arrangement, there were no statistically significant differences at the 5% 
significance level for estimated day-to-day increases or decreases in estimated CFU counts for three out of the four 
day-to-day differences.  Significant increases or decreases at the 5 percent significance level in estimated CFU 
counts over the entire follow-up period of 14 days are reported in Table 4.  Table 5 summarizes comparisons of 
significant differences at the 5 percent significance level in estimated CFU counts for selected materials by 
Microbes and follow-up Day. 
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Table 4. Overall Follow-up Microbial Change: 
Separated Suit Materials 
Material Microbes p-Value Significant 
Overall 
Increase 
Significant 
Overall 
Decrease 
BladderG Bacteria 0.7979 No No 
BladderG Fungi 0.0151 Yes No 
BladderU Bacteria <.0001 Yes No 
BladderU Fungi 0.0050 Yes No 
LCG Bacteria 0.2025 No No 
LCG Fungi 0.0263 Yes No 
LCVGL Bacteria 0.0494 Yes No 
LCVGL Fungi <.0001 Yes No 
LCVGO Bacteria <.0001 Yes No 
LCVGO Fungi 0.0011 Yes No 
TCU Bacteria 0.0531 Yes No 
TCU Fungi 0.0046 Yes No 
 
Table 5. Sources of Significant Microbial Change Due to Selected Materials: 
Separated Suit Materials 
Microbes Day BladderG 
vs 
BladderU 
LCG 
vs 
LCVGL 
LCG 
vs 
LCVGO 
LCVGL 
vs 
LCVGO 
Bacteria 1 Yes Yes Yes Yes 
Bacteria 3 Yes No Yes Yes 
Bacteria 7 Yes No Yes Yes 
Bacteria 10 Yes Yes Yes Yes 
Bacteria 14 No No Yes Yes 
Fungi 1 Yes Yes Yes Yes 
Fungi 3 Yes No Yes Yes 
Fungi 7 Yes Yes Yes Yes 
Fungi 10 Yes No Yes Yes 
Fungi 14 Yes No Yes Yes 
 
For the disinfectants and suit bladder materials, there were no statistically significant differences at the 5% 
significance level for estimated day-to-day increases or decreases in estimated CFU counts for three out of the four 
day-to-day differences.  Significant increases or decreases at the 5 percent significance level in estimated CFU 
counts over the entire follow-up period of 14 days are reported in Table 6.  The examination of sources of significant 
increases or decreases in estimated CFU counts for each follow-up day due to biocidal treatment is summarized in 
Table 7.  Significant increases or decreases in differences of estimated CFU counts due to any of the biocidal 
treatments (Alcohol, QUAT, or None) are reported in Table 8.  Significant increases or decreases in differences of 
estimated CFU counts due to materials (BladderG or BladderU) are reported in Table 9. 
 
 
Table 6. Overall Follow-up Microbial Change: 
Suit Bladder Materials 
Biocide Material Microbes p-Value Significant 
Overall 
Increase 
Significant 
Overall 
Decrease 
Alcohol BladderG Bacteria 0.4674 No No 
Alcohol BladderG Fungi <.0001 Yes No 
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Biocide Material Microbes p-Value Significant 
Overall 
Increase 
Significant 
Overall 
Decrease 
Alcohol BladderU Bacteria 1.0000 No No 
Alcohol BladderU Fungi 1.0000 No No 
None BladderG Bacteria 0.9579 No No 
None BladderG Fungi 0.2916 No No 
None BladderU Bacteria 0.0007 Yes No 
None BladderU Fungi 0.1930 No No 
QUAT BladderG Bacteria 0.0688 No No 
QUAT BladderG Fungi 0.4886 No No 
QUAT BladderU Bacteria 0.5759 No No 
QUAT BladderU Fungi 1.0000 No No 
 
Table 7. Sources of Significant Microbial Change Due to Biocide: 
Suit Bladder Materials 
Material Microbes Day Alcohol 
vs 
None 
Alcohol 
vs 
QUAT 
QUAT 
vs 
None 
BladderG Bacteria 1 No No No 
BladderG Bacteria 3 No No No 
BladderG Bacteria 7 No No No 
BladderG Bacteria 10 Yes No No 
BladderG Bacteria 14 No No Yes 
BladderG Fungi 1 Yes No No 
BladderG Fungi 3 No No Yes 
BladderG Fungi 7 No Yes Yes 
BladderG Fungi 10 Yes Yes Yes 
BladderG Fungi 14 No Yes Yes 
BladderU Bacteria 1 No No No 
BladderU Bacteria 3 No No Yes 
BladderU Bacteria 7 No No No 
BladderU Bacteria 10 No No No 
BladderU Bacteria 14 No No No 
BladderU Fungi 1 No No Yes 
BladderU Fungi 3 No No No 
BladderU Fungi 7 No No No 
BladderU Fungi 10 No No No 
BladderU Fungi 14 No No No 
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Table 8. Overall Microbial Change Due to Biocide: 
Suit Bladder Materials 
Material Microbes Day p-Value Significant 
Overall 
Increase 
BladderG Bacteria 1 0.1910 No 
BladderG Bacteria 3 0.4466 No 
BladderG Bacteria 7 0.4593 No 
BladderG Bacteria 10 0.0661 No 
BladderG Bacteria 14 0.0857 No 
BladderG Fungi 1 0.0381 Yes 
BladderG Fungi 3 0.0055 Yes 
BladderG Fungi 7 <.0001 Yes 
BladderG Fungi 10 0.0003 Yes 
BladderG Fungi 14 <.0001 Yes 
BladderU Bacteria 1 0.2482 No 
BladderU Bacteria 3 0.0002 Yes 
BladderU Bacteria 7 0.9999 No 
BladderU Bacteria 10 0.9999 No 
BladderU Bacteria 14 0.9999 No 
BladderU Fungi 1 0.0004 Yes 
BladderU Fungi 3 0.9999 No 
BladderU Fungi 7 0.9999 No 
BladderU Fungi 10 0.9999 No 
BladderU Fungi 14 0.9999 No 
 
Table 9. Sources of Significant Microbial Change Due to Material: 
Suit Bladder Materials 
Biocide Microbes Day p-Value BladderG 
vs 
BladderU 
Alcohol Bacteria 1 0.9914 No 
Alcohol Bacteria 3 0.9912 No 
Alcohol Bacteria 7 0.9911 No 
Alcohol Bacteria 10 0.9916 No 
Alcohol Bacteria 14 0.9917 No 
Alcohol Fungi 1 0.9942 No 
Alcohol Fungi 3 0.9927 No 
Alcohol Fungi 7 0.9925 No 
Alcohol Fungi 10 0.9931 No 
Alcohol Fungi 14 0.9917 No 
None Bacteria 1 <.0001 Yes 
None Bacteria 3 <.0001 Yes 
None Bacteria 7 0.0453 Yes 
None Bacteria 10 0.0274 Yes 
None Bacteria 14 0.3092 No 
None Fungi 1 0.0511 No 
None Fungi 3 <.0001 Yes 
None Fungi 7 0.0023 Yes 
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Biocide Microbes Day p-Value BladderG 
vs 
BladderU 
None Fungi 10 0.0040 Yes 
None Fungi 14 0.1723 No 
QUAT Bacteria 1 <.0001 Yes 
QUAT Bacteria 3 <.0001 Yes 
QUAT Bacteria 7 0.9912 No 
QUAT Bacteria 10 0.9914 No 
QUAT Bacteria 14 0.9919 No 
QUAT Fungi 1 0.0003 Yes 
QUAT Fungi 3 0.9934 No 
QUAT Fungi 7 0.9939 No 
QUAT Fungi 10 0.9939 No 
QUAT Fungi 14 0.9937 No 
 
For the antimicrobial materials, there were no statistically significant differences at the 5% significance level for 
estimated day-to-day increases or decreases in estimated CFU counts for three out of the four day-to-day 
differences.  Significant increases or decreases at the 5 percent significance level in estimated CFU counts over the 
entire follow-up period of 14 days are reported in Table 10.  Table 11 summarizes comparisons of significant 
differences at the 5 percent significance level in estimated CFU counts for materials by Microbes and follow-up 
Hour. 
 
Table 10. Overall Microbial Change over Follow-up Times: 
Antimicrobial Materials 
Material Microbes p-Value Significant 
Overall 
Increase 
Significant 
Overall 
Decrease 
Cupron2 Bacteria 0.0147 Yes No 
Cupron2 Fungi 0.0011 Yes No 
Cupron4 Bacteria <.0001 Yes No 
Cupron4 Fungi <.0001 Yes Yes 
Cupron5 Bacteria 0.0003 Yes No 
Cupron5 Fungi 0.0007 Yes No 
HYGY Bacteria <.0001 Yes No 
HYGY Fungi 0.0294 Yes No 
Kaos Bacteria <.0001 Yes No 
Kaos Fungi 0.0007 No Yes 
United65961 Bacteria 0.0091 Yes Yes 
United65961 Fungi <.0001 Yes No 
United80031 Bacteria 0.0147 Yes Yes 
United80031 Fungi <.0001 Yes No 
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Table 11. Sources of Microbial Change Due to Materials: 
Antimicrobial Materials 
Microbes Hour Significant 
Change 
Bacteria 3 Cupron2 vs Cupron4 
Cupron2 vs Cupron5 
Cupron2 vs HYGY 
Cupron2 vs Kaos 
Cupron4 vs United65961 
Cupron4 vs United80031 
Cupron5 vs United65961 
Cupron5 vs United80031 
HYGY vs United65961 
Kaos vs United65961 
Kaos vs United80031 
Bacteria 7 No 
Bacteria 24 Curpon4 vs Cupron5 
Cupron4 vs HYGY 
Cupron5 vs Kaos 
HYGY vs Kaos 
Bacteria 168 Cupron4 vs HYGY 
Cupron4 vs Kaos 
Cupron4 vs United65961 
Cupron4 vs United80031 
Cupron5 vs Kaos 
Cupron5 vs United65961 
Cupron5 vs United80031 
HYGY vs United65961 
HYGY vs United80031 
Kaos vs United65961 
Kaos vs United80031 
Bacteria 336 No 
Fungi 3 Cupron2 vs Cupron4 
Cupron2 vs Cupron5 
Cupron2 vs HYGY 
Cupron2 vs Kaos 
Cupron4 vs United80031 
Cupron5 vs United80031 
HYGY vs United80031 
Kaos vs United80031 
 
Microbes Hour Significant 
Change 
Fungi 7 Cupron2 vs Cupron4 
Cupron2 vs HYGY 
Cupron2 vs Kaos 
Cupron4 vs United65961 
Cupron4 vs United80031 
HYGY vs United65961 
HYGY vs United80031 
Kaos vs United80031 
United65961vs United80031 
 
Fungi 24 Cupron2 vs Cupron5 
Cupron2 vs Kaos 
Cupron4 vs Cupron5 
Cupron4 vs HYGY 
Cupron4 vs Kaos 
Cupron5 vs HYGY 
Cupron5 vs Kaos 
Fungi 168 Cupron2 vs Cupron4 
Cupron2 vs Cupron5 
Cupron2 vs HYGY 
Cupron2 vs United65961 
Cupron4 vs United80031 
Cupron4 vs Kaos 
Cupron4 vs United65961 
Cupron5 vs Kaos 
Cupron5 vs United65961 
HYGY vs Kaos 
HYGY vs United65961 
Kaos vs United65961 
Kaos vs United80031 
United65961vs United80031 
Fungi 336 Cupron2 vs Cupron5 
Cupron2 vs Kaos 
Cupron2 vs United80031 
Cupron4 vs Kaos 
Cupron5 vs Kaos 
HYGY vs Kaos 
HYGY vs United80031 
Kaos vs United80031 
 
 
A detailed examination of effect estimates and their confidence intervals shows inconclusive results that are 
likely due to an insufficient number of follow-up points and an insufficient number of replicates. Experimental 
results that show significant day-to-day changes would likely require an evenly spaced follow-up point (e.g., every 2 
days) and would also likely require a larger number of replicates (e.g., at least five replicates). 
For the stacked and individual arrangement evaluations, a similar examination shows that over the course of the 
14 days of follow-up, counts of bacterial CFUs generally increased while count of fungal CFUs generally decreased. 
IV. Conclusion 
This preliminary trade study was conducted to understand the microbial behavior of the current bladder, LCVG, 
LCG, and TCU materials and also the on-orbit bladder disinfectants. Disinfectants and antimicrobial fabrics were 
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selected from a COTS survey and tested in this study. The following conclusions apply to the 14 day duration of the 
study. 
In the stacked material arrangement, neither the EMU nor the ACES suit materials meet the CxP requirements. In 
the individual arrangement, only the EMU LCVG-O and the EMU Bladder meet completely the CxP bacterial level 
requirements. 
The test of disinfectants on the EMU bladder showed that only the bacterial levels were controlled within the CxP 
requirements 
Among the COTS antimicrobial fabrics, SILVERCLEAR
®
 controlled bacterial and fungal levels within the CxP 
requirements. The remaining seven antimicrobial fabrics controlled only bacterial levels within the CxP 
requirements. 
V. Summary and Forward Work 
We need further understanding of contamination by including more factors in the testing, such as fabric 
construction (woven, knitted, non-woven), fabric thickness, fiber type, and surface finishes, as well as microbial 
selection, concentration and mix, and additionally antimicrobial treatments and agents, and also various short- and 
long-term follow-up times. 
The next step in better understanding suit biocontamination should include isolating one or more of the many 
variables shown in this study. The three leading candidates include: fabric construction, fabric treatment, and 
microbe type. Since two of these variables primarily apply to the TCU, the next phase of testing should focus on the 
TCU layer. Future testing will eventually be needed to evaluate the bladder and LCGV layers; however, since the 
TCU appears primarily to contain the highest CFU counts, this garment is a good focus layer for the next phase of 
testing. 
The first part of the next phase of testing should focus on better understanding the effect of differences in fabric 
construction on microbial growth. The Cupron
™
 samples tested in the preliminary study used similar materials and 
treatments, but different fabric constructions, which is assumed to be one reason for microbial growth differences. 
Therefore, the first part of this test should use different constructions of a similar base material with similar fabric 
treatments. These fabric constructions should be subjected to microbial contamination and growth to understand this 
behavior better. 
The second part of the next phase of testing should focus on better understanding the effect of fabric treatment 
on microbial growth. The results of the antimicrobial materials test suggest that the materials treated with silver- and 
copper-ion fabrics show potential for controlling microbial growth, but each of these materials also used different base 
materials and contained different fabric constructions. The second part of this test should use several different silver 
and copper fabric treatments on similar base materials with similar fabric constructions. These various fabric 
treatments should be subjected to microbial contamination and growth to understand this behavior better. 
The third part of the next phase of testing should focus on better understanding the effect of competing microbial 
growth. The results in Section III of this paper indicated all Staphylococcus epidermidis was eliminated prior to the 
first sampling, and it is not known whether this was due to competition with other bacteria or fungi. Furthermore, it 
appeared that there may have been some level of microbial competition between the remaining microbes during the 
14-day test period. An extended test period would help to understand better when this competition stabilizes. The 
next phase of proposed testing will therefore first seek to determine better how each microbe colonizes on antimi-
crobial materials by itself, to understand better how these microbes behave when placed together in a competing 
environment. By testing the colonization of only one microbe at a time on similar base materials that have similar 
weaves and fabric treatments, the colonization behavior of each microbe on antimicrobial materials can better be 
comprehended. 
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